Klobetazol Belupo (Clobetasol Propionate)

Clobetasol propionate is a potent topical corticosteroid used to manage inflammatory skin conditions. It is commonly prescribed for short‑term control of these conditions.

• Psoriasis: reduces plaque thickness, scaling, redness and associated itching, improving skin appearance.
• Eczema: alleviates itching, inflammation and skin irritation, helping restore barrier function.
• Dermatitis: controls redness, swelling and discomfort, promoting faster healing of affected areas.
• Lichen planus: diminishes lesions and associated itching, reducing chronic inflammation.
• Atopic dermatitis: reduces flare severity and itching, supporting skin recovery.

• Clobetasol propionate penetrates the epidermis and binds to intracellular glucocorticoid receptors. The activated receptor complex translocates to the nucleus and modulates gene transcription, suppressing pro‑inflammatory cytokines, chemokines and adhesion molecules while inducing anti‑inflammatory proteins. This results in reduced vasodilation, edema, leukocyte infiltration and fibroblast activity, providing potent anti‑inflammatory, immunosuppressive and vasoconstrictive effects in the skin. The overall effect leads to rapid symptom relief and lesion thinning.

Topical clobetasol propionate may cause local and systemic adverse reactions, most of which are related to its corticosteroid activity.

Common Side Effects

• Skin irritation or burning sensation.
• Dryness or peeling of the treated area.
• Redness or mild erythema.
• Pruritus (itching) at the application site.
• Folliculitis or acneiform eruptions.

Serious or Rare Side Effects

• Skin atrophy or thinning with prolonged use.
• Telangiectasia (visible small blood vessels).
• Hypopigmentation or depigmentation of the skin.
• Secondary infection (bacterial, fungal or viral).
• Systemic corticosteroid effects such as adrenal suppression.
• Allergic contact dermatitis.

When using clobetasol propionate, several precautions should be observed to minimize risks and ensure safe therapy.

• Apply only to intact skin: avoid broken or infected areas.
• Limit treatment duration: use for the shortest period necessary, typically up to 2 weeks.
• Avoid occlusion: do not cover treated skin with dressings unless directed by a physician.
• Do not use on large body surface areas: restrict to affected sites to reduce systemic absorption.
• Monitor for signs of adrenal suppression: report unusual fatigue, weakness or hypotension.
• Store at room temperature: keep in the original container, protect from moisture and light.

Clobetasol propionate can interact with other medications, altering its absorption or enhancing systemic corticosteroid effects.

Major Interactions (Avoid)

• Systemic corticosteroids: additive systemic glucocorticoid effects may increase risk of adrenal suppression.
• Antifungal agents (e.g., ketoconazole): inhibit metabolism and raise local drug levels, raising irritation risk.
• Immunosuppressants (e.g., cyclosporine): may enhance immunosuppressive action, increasing infection susceptibility.

Moderate Interactions (Monitor Closely)

• Vaccines (live attenuated): topical steroids may diminish immune response to vaccination.
• Photosensitizing drugs (e.g., tetracyclines): combined use may increase risk of photosensitivity reactions.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): concurrent use may heighten risk of systemic side effects if absorption occurs.